Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Caughey

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Infectious Disorders Drug Targets|February 10, 2009
Recent advances in prion chemotherapeuticsValerie L Sim, Byron Caughey
The Journal of Biological Chemistry|February 21, 2003
Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoformGerald S Baron, Byron Caughey
Nature|October 17, 2003
Prion diseases: a nucleic-acid accomplice?Byron Caughey, David A Kocisko
Annual Review of Neuroscience|April 22, 2003
Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystandersByron Caughey, Peter T Lansbury
Journal of Virology|December 28, 2005
Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivoDavid A Kocisko, Byron Caughey
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
A simplified recipe for prionsKil Sun Lee, Byron Caughey
Neurobiology of Aging|April 9, 2008
Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrilsValerie L Sim, Byron Caughey
Clinics in Laboratory Medicine|July 29, 2020
Proteopathic Seed Amplification Assays for Neurodegenerative DisordersNatália do Carmo Ferreira, Byron Caughey
Current Opinion in Pharmacology|November 10, 2018
Cell-free prion protein conversion assays in screening for anti-prion drug candidatesNatália do Carmo Ferreira, Byron Caughey
The New England Journal of Medicine|November 6, 2014
A test for Creutzfeldt-Jakob disease using nasal brushingsGianluigi Zanusso, Matilde Bongianni, Byron Caughey
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Infectious Disorders Drug Targets|February 10, 2009
Recent advances in prion chemotherapeuticsValerie L Sim, Byron Caughey
The Journal of Biological Chemistry|February 21, 2003
Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoformGerald S Baron, Byron Caughey
Nature|October 17, 2003
Prion diseases: a nucleic-acid accomplice?Byron Caughey, David A Kocisko
Annual Review of Neuroscience|April 22, 2003
Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystandersByron Caughey, Peter T Lansbury
Journal of Virology|December 28, 2005
Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivoDavid A Kocisko, Byron Caughey
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
A simplified recipe for prionsKil Sun Lee, Byron Caughey
Neurobiology of Aging|April 9, 2008
Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrilsValerie L Sim, Byron Caughey
Clinics in Laboratory Medicine|July 29, 2020
Proteopathic Seed Amplification Assays for Neurodegenerative DisordersNatália do Carmo Ferreira, Byron Caughey
Current Opinion in Pharmacology|November 10, 2018
Cell-free prion protein conversion assays in screening for anti-prion drug candidatesNatália do Carmo Ferreira, Byron Caughey
The New England Journal of Medicine|November 6, 2014
A test for Creutzfeldt-Jakob disease using nasal brushingsGianluigi Zanusso, Matilde Bongianni, Byron Caughey
Pageof 19